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 Quinones are compounds that have various characteristics such as biological 
electron transporter, therapeutic agent and harmful environmental pollutant.  
Therefore, an effective analytical method for quinones is useful in many fields 
including biomedical, clinical and toxicological studies.  This review describes the 
principle and feature of analytical techniques for quinones including high-
performance liquid chromatography with ultraviolet, fluorescence, 
chemiluminescence, electrochemical detection and mass spectrometry, gas 
chromatography with mass spectrometry and capillary electrophoresis.  Furthermore, 
the sensitivity and the sample preparation method for the determination of several 
quinones such as vitamin K, ubiquinone, doxorubicin and polycyclic aromatic 
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BHT, butylated hydroxytoluene 
CE, capillary electrophoresis 
CL, chemiluminescence 
CoQ10, coenzyme Q10 
DHPA, 3,6-dihydroxyphthalic acid 
DXR, doxorubicin 
DXR-ol, doxorubicinol 
ECD, electrochemical detection 
ELISA, enzyme linked immunosorbent assay 
ESI, electrospray ionization 
FL, fluorescence 
GC-MS, gas chromatography with mass spectrometry 
HPLC, high performance liquid chromatography 
PAHQ, polycyclic aromatic hydrocarbon quinone; 
PFBHA, O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine 
PK, phylloquinone 
PO-CL, peroxyoxalate chemiluminescence 
PQ, 9,10-phenanthrenequinone 
ROS, reactive oxygen species 
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SDS, sodium dodecyl sulfate 
LOD, limit of detection 
LOQ, limit of quantification 
MEEKC, microemulsion electrokinetic chromatography 
MK, menaquinone 
MS, mass spectrometry 







Quinones are interesting compounds which have unique characteristics and 
several important roles.  Quinones are widely distributed compounds in the nature 
including plant and animal tissues.  Quinones have an important role in the electron 
transport chain to maintain biological functions of plants and animals.  It is well 
known that plastoquinone is involved in the light-dependent photosynthetic reactions 
in plants.  In the animal system, ubiquinone (UQ, other name for coenzyme 
Q10(CoQ10)) acts as an electron carrier in the mitochondrial electron transport chain 
and participates in aerobic cellular respiration and energy production [1, 2].  Also, 
quinone structures are related to some vitamins.  Vitamin K is a structurally related 
group of 2-methyl-1, 4-naphthoquinone derivatives having either a phytyl side chain 
(phylloquinone (PK), vitamin K1), or a side chain with repeated isoprenoid units 
(menaquinones (MKs), vitamin K2).  It was known that vitamin K has a beneficial 
role in blood coagulation, bone metabolism and growth [3-5].  α-Tocopherol, known 
as vitamin E, is oxidized to tocopherylquinone during the process of antioxidation [6].  
It is conceivable that tocopherylquinone concentrations may be increased under 
pathological conditions.  Recently, it has been reported that pyrroloquinoline quinone 
is nutritionally important as a vitamin in mammals [7]. 
In addition to these biological roles, quinones have been used in a wide variety 
of clinical practice and industrial application.  For example, doxorubicin (DXR) is an 
anthraquinone (AQ) antibiotic that has been used clinically in the treatment of 
malignant tumors [8].  AQ derivatives such as rhein, the principle active constituents 
of traditional Chinese herb rhubarb, have immunosuppressive and anti-inflammatory 
effects [9].  The structures of these AQ drug are shown in Fig. 1.  Vitamin K is 
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clinically applied for the treatment of several diseases including osteoporosis and 
vitamin K deficiency symptoms [5].  In addition, AQ derivatives are used as a large 
class of dyes and pigments [10]. 
While quinones have several beneficial effects mentioned above, they are 
regarded as a class of toxins which can cause a variety of hazardous effects on living 
cells.  For example, quinones act as a generator of reactive oxygen species (ROS) 
through the redox cycle in biological system and ROS can induce several types of 
oxidative damage such as lipid peroxidation [11, 12].  Additionally, some quinones 
such as 9,10-phenanthrenequinone (PQ) serve as an inhibitor of certain enzymes, for 
example, nitric oxide synthase or glyceraldehyde-3-phosphate dehydrogenase, by the 
covalent binding to the active site of enzymes [13,14].  In the atmospheric 
environment, the presence of polycyclic aromatic hydrocarbon quinone (PAHQ) 
including PQ was confirmed [15].  It was thought that PAHQs are formed by photo-
oxidation of polycyclic aromatic hydrocarbons (PAHs) that are mainly released from 
motor vehicle engines in atmosphere (Fig. 2).  PAHQ in atmospheric environment is 
considered to be involved in the pathogenesis of respiratory diseases [16].   
From these aspects, the determination method of quinones in biological and 
environmental samples should be important in various fields including the 
investigation of physiological properties of quinone, therapeutic monitoring of 
quinone drugs and the estimation of risk of toxic quinones on human health.  In this 
review, the principle and the feature of analytical techniques for quinones especially 
vitamin K, UQ, DXR and PAHQ are described according mainly to the recent reports.  
Furthermore, the sensitivity and the sample preparation method for the determination 
of these quinones in biological and environmental samples are summarized in Tables.  
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2. Analytical techniques for quinones  
Until now, various analytical methodologies have been developed for the 
determination of quinones.  In the following section, the principle and the feature of 
analytical techniques for quinones are described. 
 
2.1 High-performance liquid chromatography (HPLC) 
 Chromatographic separation is one of the techniques of choice for the analysis 
of various compounds in complicated matrices.  Thus, HPLC is one of the most 
frequently used tools for the analyses of quinones in biological and environmental 
samples.  Several detection techniques including ultraviolet (UV), fluorescence (FL), 
chemiluminescence (CL), electrochemical detection (ECD) and mass spectrometry 
(MS) have been coupled with HPLC analysis.    
 
2.1.1 HPLC-UV 
HPLC with UV detection method is most common and widespread due to its 
easy handling nature.  Various HPLC-UV methods for quinones have been developed 
because most of quinones have absorbance at UV region [17-20].  However, the 
sensitivity of UV detection is insufficient to determine trace amount of quinones.  
Also, the selectivity of UV detection is generally low because co-existing UV-
absorbing compounds can interfere with the detection of quinones.  Even though the 
low sensitivity and selectivity, HPLC-UV has been frequently utilized for the 
simultaneous determination of quinones and other types of compounds due to its 
universality.  For example, vitamin K and UQ were determined with other fat soluble 
vitamins such as retinol (vitamin A) and α-tocopherol in biological fluids [17,18].    
Also, simultaneous determination method for co-administered anticancer drugs 
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including DXR and 5-fluorouracil was developed by HPLC-UV in order to explore 
the synergistic effects between these drugs [19].  
 
2.1.2 HPLC-FL 
Since FL detection is usually sensitive and selective than UV detection, a large 
number of chemicals were measured by HPLC with FL detection technique.  Among 
quinones, AQ derivatives such as DXR and rhein have strong FL itself, thus these 
compounds were determined directly by HPLC-FL [21. 22].  However, most of 
quinones do not have intrinsic FL.  Therefore, several FL derivatization reactions 
were developed for the conversion of non- or weakly fluorescent quinone to strongly 
fluorescent derivative. 
The most simple derivatization reaction is the reduction of quinone to 
fluorescent hydroquinone and this reaction has frequently been applied to determine 
vitamin K in biological samples by HPLC-FL.  Vitamin K (NQ derivative) was 
reduced to corresponding hydronaphthoquinone and it was detected at excitation and 
emission wavelengths of 240 or 320 and 430 nm, respectively.  Several chemical 
reductants such as sodium borohydride, zinc and platinum were used for the FL 
derivatization of vitamin K.  Sodium borohydride solution was used as a post column 
derivatization reagent [23].  Zinc was usually packed in a stainless steal column and it 
was incorporated as an on-line reactor between an analytical column and a 
fluorescence detector [24].  A platinum catalyst reduction column was also used as an 
on-line reactor for the reduction of vitamin K [25] and it was known that the 
durability of platinum was higher than that of zinc.  In addition to chemical reduction, 
electrochemical or photochemical reduction was also employed for the FL 
derivatization of vitamin K.  In an HPLC system coupled with an on-line 
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electrochemical reactor, vitamin K was reduced prior to fluorescence measurements 
by applying a negative voltage [26, 27].  A photochemical reactor constructed of 
PTFE tubing coiled around a low-pressure mercury lamp could reduce vitamin K to 
hydronaphthoquinone in the presence of sodium dodecyl sulfate (SDS) and methanol 
[28].  The direct reductive derivatization reaction was also applied for quinones other 
than vitamin K.  Pollok and Melchert developed an HPLC-FL system with on-line 
photoreactor for the determination of tocopherylquinones in human serum [29].  In 
this HPLC system, tocopherylquinones were reduced to corresponding 
tocopherylhydroquinone under UV irradiation and they were detected at 331 nm with 
an excitation at 294 nm.  Also, the performance of the photochemical reactor 
compared with that of a zinc catalyst reduction column as the reduction system for 
tocopherylquinone, and it was concluded that the reducing ability of zinc was 
deteriorated within short time.  Kameda et al. used a platinum-rhodium catalyst 
column for the conversion of benz[a]anthracene-7,12-quinone (BaAQ), one of PAHQ 
detected in airborne particulates, to dihydroxybenz[a]anthracene which show 
fluorescence at 465 nm with an excitation at 285 nm [30].  On the other hand, a 
reduction of UQ to ubiquinol for the FL determination of UQ was not practical 
because the sensitivity of HPLC-FL detection of ubiquinol reduced from UQ was 
inferior to that of HPLC-UV detection of UQ [31].   
Other than reductive derivatization reaction, several reagents were developed 
for the FL derivatization of quinones.  It was found that PQ could be converted to 
strongly fluorescent lophine derivative by the reaction with benzaldehyde in the 
presence of ammonium acetate (Fig. 3) [32].  Based on this reaction, an HPLC 
method for the determination of PQ in airborne particulates was developed using pre-
column derivatization and FL detection.  Furthermore, 4-carbomethoxybenzaldehyde 
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was discovered as the most suitable derivatization reagent for PQ compared to other 
aldehyde because the derivative shows stronger fluorescence at longer wavelength 
legion [33].  Additionally, a simple and rapid determination method for PQ was 
developed by HPLC with post-column derivatization and FL detection.  This method 
was based on the reaction of PQ with 2-aminothiophenol under acidic condition to 
form fluorescent derivative, which emits green fluorescence at 510 nm [34].  On the 
other hand, Nohara et al. developed an HPLC with post-column FL derivatization 
method for the determination of UQ in plasma using 2-cyanoacetoamide as a reagent.  
They reported that 2-cyanoamide reacted with UQ under alkaline conditions through 
Craven’s reaction to form fluorescent derivative, which emits fluorescence at 549nm 
with an excitation at 442 nm [35]. 
 
2.1.3 HPLC-CL 
Among several detection methodologies, it is well known that CL detection 
has numerous advantages owing to its high sensitivity, selectivity and wide linear 
working ranges.  However, quinone cannot be detected directly by CL because 
quinone cannot react with CL reagents such as luminol and diaryl oxalate.  Therefore, 
a redox or photochemical reaction was applied to convert quinone to ROS, which can 
be sensitively detected by CL [36].  
A unique CL assay for quinones including UQ based on their redox reaction 
cycle was developed [37].  In this assay, quinones were reduced to semiquinone 
radicals by dithiothreitol (DTT) as a reductant.  Successively, semiquinone radicals 
convert dissolved oxygen to superoxide anion, which reacts with luminol to generate 
CL (Fig. 4).  An HPLC- CL method based on this CL reaction system was developed  
for the determination of UQ in plasma samples [38]. 
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An HPLC method was developed for the determination of quinones with 
peroxyoxalate chemiluminescence (PO-CL) detection following on-line UV 
irradiation.  This method was based on conversion of quinones to hydrogen peroxide 
and a fluorescent photoproduct, 3,6-dihydroxyphthalic acid (DHPA) under UV 
irradiation, and the liberated hydrogen peroxide was detected by PO-CL reaction via 
only mixing with diaryl oxalate [39].  The proposed HPLC-PO-CL system was 
applied for the determination of vitamin K [40] and DXR [41] in plasma samples.  
Additionally, it was noticed that DHPA has a strong catalytic effect on luminol CL 
[42].  The photogeneration of the enhancer (DHPA) in association with the ROS in 
that photochemical reaction greatly increases the light output of luminol CL.  This 
phenomenon allowed the development of a highly sensitive and selective HPLC-CL 
method for the determination of quinones.  The developed HPLC-luminol CL method 
was successfully applied to determine PAHQs such as NQ, PQ and AQ in airborne 
particulates or to determine vitamin K in plasma sample obtained from rheumatoid 
arthritis patients [43]. 
 On the other hand, Li et al. reported an HPLC-CL method for the 
determination of benzo[a]pyrene-7,10-quinone (BaPQ) in airborne particulates [44].  
The method is based on the enhancement effect of BaPQ on the CL generated from 
the reaction between sodium hydrosulfite and hydrogen peroxide.   
 
2.1.4 HPLC-ECD  
 HPLC-ECD is a sensitive and suitable method for the determination of 
compounds having electrochemical activity.  Since quinones are electroactive species, 
HPLC-ECD should be an effective analytical method for quinones.  However, 
quinone has to be detected with ECD in the reductive mode.  In the reductive mode, 
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complicated degassing instruments are required in order to remove the influence of 
dissolved oxygen in mobile phase.  Thus, quinone is usually reduced to hydroquinone 
prior to measurement with ECD in the oxidative mode.  Where, the signal response 
was achieved with the re-oxidation of hydroquinone to quinone.   
 The HPLC-ECD methods after quinones reduction were frequently used for 
the determination of UQ in biological samples.  Chemical reductants such as sodium 
borohydride, zinc and platinum could be used for the reduction of UQ in a similar 
way to the reductive FL derivatization of quinone.  Sodium borohydride was added to  
UQ solution as a pre-column reductant and then the mixture was injected into an 
HPLC-ECD system [45, 46].  Leray et al. reported an HPLC-ECD system that was 
equipped with a column packed with zinc for the post-column reduction of UQ, and 
the HPLC system was applied to the simultaneous determination of UQ and 
tocopherylquinone [47].  HPLC-ECD systems having a platinum catalytic reduction 
column placed downstream of an analytical column were also developed [48-50].  An 
on-line electrochemical reactor was also used to convert UQ to ubiquinol for an 
HPLC-ECD analysis.  UQ was reduced by applying a negative voltage after the 
separation, and the formed ubiquinol was re-oxidized by applying positive voltage to 
measure UQ (Fig. 5) [51-53].  Additionally, HPLC-ECD methods with a platinum 
catalyst reduction column and with an on-line electrochemical reactor were applied to 
the determination of vitamin K [54] and DXR [55] in blood sample, respectively.    
 
2.1.5 LC-MS 
LC-MS is a sensitive and selective method, and provides not only quantitative 
information but also qualitative information.  Even though the instruments for MS are 
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expensive and not widespread, the application of LC-MS or LC-MS/MS for the 
determination of a variety of quinones has been increasing.  
Since ionization efficiency of analyte influences on the sensitivity in LC-MS 
analysis, the selection of appropriate ionization mode should be important.  Usually, 
four types of ionization mode are available, namely, atmospheric pressure chemical 
ionization (APCI) in the positive ion mode (APCI(+)), APCI in the negative ion mode 
(APCI(-)), electrospray ionization (ESI) in the positive ion mode (ESI(+)) and ESI in 
the negative ion mode (ESI(-)). 
 The ionization of vitamin K for LC-MS was usually performed using APCI 
(+).  Ducros et al. compared the performance between APCI(+) and ESI(+) in the 
analysis of PK by LC-MS/MS, it was reported that the APCI gave a 5-fold higher 
signal-to-noise ratio than ESI [56].  Sano et al. concluded that ESI was not suitable for 
the ionization of MK because several adduct ions were formed by ESI [57].  Likewise, 
Suhara et al. employed an LC-MS/MS with APCI(+) for the simultaneous 
determination of PK and MKs [58].  The ionization of tocopherylquinone for LC-
MS/MS analysis was also performed using APCI(+) like vitamin K [59]. 
 Hansen et al. compared the chromatograms of UQ in serum extract obtained 
by LC-MS with four ionization modes [60].  They concluded that the APCI(-) was 
most convenient by considering the peak intensity of UQ against the intensities of 
interfering peaks derived from serum components.  While, Li et al. employed an LC-
MS with APCI(+) for the determination of UQ in rat plasma [61].  In addition, an LC-
MS/MS with ESI(+) was used to determine UQ in human serum [62].  In this way, it 
seems to be no consensus on the ionization mode for UQ.  Teshima and Kondo 
mentioned that the ionization efficiency of UQ was poor.  In order to improve the 
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ionization efficiency of UQ, they added methylamine as an ionization-supporting 
agent to the mobile phase of LC-MS/MS with APCI(+) system [63].      
 The ionization of AQ derivative was usually performed using ESI interface.  
Arnold et al. mentioned that ESI provided greater sensitivity than APCI for the 
detection of DXR by LC-MS/MS [64].  DiFranceso also used an LC-MS/MS with 
ESI (+) for the simultaneous determination of DXR and their hydoxylated metabolites, 
doxorubicinol (DXR-ol) in biological samples [65].  In contrast, rhein that has only 
carboxylic and hydroxyl group was determined by an LC-MS/MS with ESI(-) [66, 67].   
 The ionization of PAHQ detected in atmospheric environment was performed 
using APCI interface.  Both the positive and negative ion modes have been used for 
LC-MS analysis of PAHQ.  Lintelmann et al. employed APCI(+) for the LC-MS/MS 
analysis of PAHQ [68, 69].  On the other hand, Mirivel et al. employed APCI(-) 
considering the electrophilic nature of PAHQ [70].  Delhomme et al. compared the 
sensitivity of PAHQ between APCI(+) and APCI(-) [71].  As a result, limit of 
detections (LODs) obtained by APCI(-) (0.19-1.20 µg/L) were more sensitive than 
those (1.28-7.00 µg/L) obtained by APCI(+).  Jakober et al. reported the 
derivatization method of PAHQ with O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine 
(PFBHA) in order to improve the ionization efficiency in LC-MS/MS with APCI 
interface [72].  The application of PFBHA enhanced the sensitivity of PAHQ both in 
positive and negative ion modes.  Although the negative ion mode gave better 
sensitivity for PAHQ without derivatization, the better sensitivity was obtained in the 
positive ion mode after derivatization. 
 
2.2. Gas chromatography with mass spectrometer (GC-MS) 
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 Since GC-MS is sensitive and offers higher resolution than LC, it is also 
widely used in biomedical and environmental analysis.  However, due to low vapor 
pressure and ionization efficiency of quinone, derivatization to improve volatility is 
necessary before GC-MS analysis.   Several GC-MS methods have been developed 
for the determination of PK and PAHQ in biological and environmental samples.   PK 
was firstly reduced by zinc to form chromanol and remaining hydroxyl group was 
esterified with perfluoroacyl anhydride such as heptafluorobutyric  anhydride (Fig. 6) 
[73,74].  Fauler et al. compared the potential of three perfluoroacyl anhydrides 
including trifluoroacetic-, pentafluoroproiponic- and heptafluorobutyric anhydride for 
GC-MS analysis of PK in plasma, and reported that heptafluorobutyryl derivative 
showed the least interference from plasma components owing to its high molecular 
mass.  In a similar way, PAHQ including NQ was reduced to hydroquinone by zinc 
and hydroxyl groups were esterified with acetic anhydride [75].  It was reported that 
the derivatization with zinc and acetic anhydride could improve the sensitivity of 1,2-
NQ by approximately 100 times.  On the other hand, Jakober et al. used PFBHA as a 
derivatization reagent for GC-MS analysis of PAHQ to form oxime derivative [76].   
It was reported that the sensitivity of the oxime derivative of benzoquinone by GC-
MS was 4 times higher than LC-APCI-MS.  
 
2.3. Capillary electrophoresis (CE) 
 CE methods were developed for rapid analysis of quinone in blood samples.  
UQ in human plasma extract was separated from plasma components by 
microemulsion electrokinetic chromatography (MEEKC), which allows separation of 
neutral compounds, and UQ was detected at 275 nm of absorbance [77].  DXR in 
human plasma was also determined by CE with UV detection [78].  Furthermore, CE 
 16 
with laser-induced FL detection was developed for the sensitive determination of 
DXR in human serum.  In this method, DXR was detected at a wavelength of 560 nm 
with an excitation at 488 nm by argon-ion laser [79]. 
 
2.4. Other analytical techniques 
 A voltammetric determination method for DXR in human plasma was reported.  
The method was based on measurement of the current originating from the reduction 
of DXR at nanoTiO2-modified electrode [80].  An immunosensor for DXR was 
developed by immobilization of a DXR-specific antibody on to the gold nanoparticles 
modified electrode [81].  The immunosensor could determine DXR in human serum 
without interference from biological components.  An indirect competitive enzyme 
linked immunosorbent assay (ELISA) was developed for the specific determination of 
menadione (2-methyl-1, 4-naphthoquinone) [82].  The monoclonal antibody used in 
the assay was prepared by ovalbumin modified with plumbagin (2-hydroxy-1, 4-
naphthoquinone) as a hapten protein.  Due to the specificity of antigen-antibody 
interaction, the ELISA could determine menadione in fetal calf serum without any 
pre-treatment procedure.  Recently, a microplate based CL assay was developed for 
the rapid determination of quinone using a time resolved fluorescence microplate 
reader [83].  In this assay, quinone was pulse UV irradiated to form ROS that react 
with luminol analogue, L-012, and the generated CL was monitored during 1500 µs.  
The microplate assay allowed the rapid determination of menadione in human serum 
within short time. 
 
2.5. Advantages and drawbacks of each analytical technique for quinone 
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 Analytical techniques described above have several advantages and drawbacks. 
Although HPLC-UV system is easy handling and spread widely, HPLC-UV methods 
lack sensitivity and suffer from interferences from co-existing compounds.  Therefore, 
complex and laborious enrichment and clean-up procedure is often required to 
determine quinone in biological and environmental samples.  HPLC-FL methods have 
sufficient sensitivity and selectivity to determine trace amount of quinone.  However, 
the derivatization reaction procedure is necessary for the conversion of quinone to 
fluorescent derivative, and total analysis time may be extended.  In spite of excellent 
sensitivity of HPLC-CL, only a few methods were developed for the determination of 
quinone.  This might be due to the scarcity of conversion reaction of quinone to ROS.  
Although HPLC-ECD methods are sensitive, HPLC system is tend to be complicated 
because quinone should be converted to hydorquinone with reduction column or on-
line electrochemical reactor just before the detector.  While, HPLC-ECD system is 
useful for the simultaneous determination of quinone and hydorquinone.  LC-MS and 
GC-MS may be an ideal analytical tool for quinone in biological and environmental 
samples considering to their sensitivity and specificity.  However, the high cost of the 
mass spectrometer limits the widespread use.  Moreover, GC-MS methods require the 
conversion reaction of quinone to volatile derivative.  CE based methods are suitable 
for the rapid analysis of quinone, but the concentration sensitivity of CE is inherently 
low. 
 
3. Measurement of quinones in biological and environmental samples 
 In the following sections, the analytical applications for the determination of 
quinones including vitamin K, UQ, DXR and PAHQ by analytical techniques 
mentioned above are described.  The applications are also summarized in Tables with 
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sample amount, preparation procedure, analytical technique and sensitivity 
(LOD/LOQ).  
 
3.1 Vitamin K in blood samples 
 Vitamin K is an essential cofactor in the activation of specific proteins 
involved in blood clotting and bone mineralization such as prothrombin and 
osteocalcin.  In Japan, PK is often prescribed to treat and prevent for vitamin K 
deficient syndromes and MK is used orally to treat osteoporosis and steroid-induced 
bone loss.  In order to evaluate the clinical and nutritional status, the monitoring of 
vitamin K levels should be important.  Analytical applications for vitamin K in blood 
samples are summarized in Table 1. 
 After the protein precipitation with alcohol, the extraction of vitamin K from 
blood samples was almost accomplished with a hydrophobic organic solvent such as 
n-hexane owing to lipophilic character of vitamin K.  In addition, solid-phase 
extraction (SPE) with ODS or silica was sometimes used to remove interfering 
components from blood samples.  Among the analytical methods for vitamin K, 
HPLC-FL with a platinum catalyst reduction column [25] and LC-APCI(+)-MS/MS 
[56] provided efficient sensitivity. 
  
3.2 UQ in blood samples 
 UQ in blood protects circulating lipoproteins against oxidative damage due to 
their antioxidant capacity, and therefore the blood concentration of UQ may reflect 
the redox status in the human body.  Furthermore, it has been reported that the plasma 
levels of UQ in patients with certain diseases including hyperthyroidism, melanoma, 
cystic fibrosis, and phenylketonuria and mevalonic aciduria are significantly lower 
 19 
than those in healthy subjects.  Therefore, the determination of UQ in blood can also 
be useful for diagnosis of these diseases.  Analytical applications for UQ in blood 
samples are summarized in Table 2. 
 Since UQ is lipophilic compound like vitamin K, the extraction is also 
accomplished with a hydrophobic organic solvent.  While, some methods based on 
LC-APCI(+)-MS employed a simple protein precipitation for the sample preparation.  
In human body, it was reported that almost of UQ is presented as ubiquinol, and 
ubiquinol is converted to UQ during the sample preparation procedure such as 
evaporation of solvent [50].  Therefore, an antioxidant such as butylated 
hydroxytoluene (BHT) was sometimes added in order to prevent the oxidation of 
ubiquinol [51, 52].  Also, in some methods, the extract was injected immediately and 
directly for HPLC analysis without evaporation [49, 50].  This procedure was useful 
to investigate the UQ to ubiquinol ratio in blood that could be used as a marker of 
oxidative stress [84].   In contrast, some methods added an oxidant such as hydrogen 
peroxide [38] or 1, 4-benzoquinone [60] in order to oxidize ubiquinol completely.  
HPLC-ECD with a platinum catalyst reduction column [50] should be suitable for the 
determination of UQ in blood samples considering to its excellent sensitivity. 
 
3.3 DXR in blood samples 
 Although DXR has been used in the treatment of a wide range of malignant 
tumors, the clinical use of DXR is limited by a cumulative dose-dependent 
irreversible chronic cardiomyopathy.  An administration schedule that produces a low 
peak plasma drug concentrations can prevent DXR-induced cardiotoxicity.  
Additionally, DXR is rapidly metabolized in liver to DXR-ol, which also causes 
cardiotoxicity.  Taking these aspects into account, it is clinically important to 
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determine blood concentrations of DXR and DXR-ol.  Analytical applications for 
DXR and DXR-ol in blood samples are summarized in Table 3. 
 Only simple protein precipitation with an organic solvent was used for the pre-
treatment of DXR in blood sample.  Some methods employed a SPE with Oasis HLB 
column after dilution with water.  HPLC-CL should have significant advantage 
considering to the sensitivity against the required sample amounts [41].  
 
3.4 PAHQ in airborne particulates 
 PAHQs are regarded as harmful pollutants which have been detected in 
environmental samples including airborne particulates.    It was proven that PAHQ 
has significant toxicity on living cell.  Thus, it has been reported that several 
respiratory diseases, such as asthma and inflammation, can be caused by inhalation of 
PAHQ in the air.  Therefore, it is necessary to measure the concentration of PAHQ in 
the atmospheric environment in order to evaluate the potential adverse effects of 
PAHQ on human health.  Analytical applications for PAHQs in airborne particulates 
are summarized in Table 4. 
 Solvent extraction by ultrasonication is most frequently used for the extraction 
of PAHQ from airborne particulates.  Also, in order to avoid degradation of PAHQ 
during the ultrasonic extraction, accelerated solvent extraction techniques under high 
pressure are often used [69].  HPLC-FL methods after pre-column derivatization with 
banzaldehyde provided [32, 33] a good sensitivity even though the analytical 
instruments are very simple.  This technique was successfully applied to evaluate the 





 This review described various analytical methods for quinones and their 
application in biological and environmental samples.  Although the detection of 
quinones in complicated matrices is seemed to be difficult, various techniques make it 
possible to analyze quinones with high sensitivity.  Each technique has various 
characteristics in regard to sensitivity, specificity and simplicity.  It is important to 
choose the appropriate detection methods according to the characteristics of target 
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Figure captions  
 
Fig. 1. Structures of anthraquinone (AQ) derivative drug, doxorubicin and rhein. 
 
Fig. 2.  The formation of polycyclic aromatic hydrocarbon quinones (PAHQs) by 
photo-oxiaiton of polycyclic aromatic hydrocarbons (PAHs). 
 
Fig. 3.  Fluorogenic derivatization of phenanthrenequinone (PQ) with benzaldehyde 
and ammonium acetate.  
 
Fig. 4.  Chemiluminescence assay for quinones based on generation of reactive 
oxygen species through the redox cycle of quinone. 
 
Fig. 5. Reduction of ubiquinone (UQ) to ubiquinol, and re-oxidation of ubiquinol to UQ. 
 
Fig. 6. Derivatization of phylloquinone (PK) with heptafluorobutyric anhydride 





Fig. 1.  Structures of anthraquinone (AQ) derivative drug, doxorubicin and rhein. 
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Fig. 2.  The formation of polycyclic aromatic hydrocarbon quinones (PAHQs) by 



















Fig. 3.  Fluorogenic derivatization of phenanthrenequinone (PQ) with benzaldehyde and 
ammonium acetate. 
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Fig. 4.  Chemiluminescence assay for quinones based on generation of reactive 
oxygen species through the redox cycle of quinone. 
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Fig. 6. Derivatization of phylloquinone (PK) with heptafluorobutyric anhydride 




Table 1 Analytical methods for the determination of vitamin K in blood samples. 
Sample 
(volume) 




Protein precipitation with 
acetonitrile, then the 
supernatant was cleaned 
by Bakerbond cyclohexyl 
cartridge. 
HPLC-UV (abs: 280 nm) 0.6 ng (PK), 




Extraction with n-hexane 
after protein precipitation 
with isopropanol. 
HPLC-FL after post-
column reduction with 
NaBH4 (ex: 320 nm, em: 
430 nm) 
0.4 ng (PK), 





Extraction with n-hexane 
after protein precipitation 
with ethanol, then the 
extract was cleaned by 
Sep-Pak silica cartridge. 
HPLC-FL with a zinc 
catalyst reduction column 
(ex: 240 nm, em: 430 nm) 





Extraction with n-hexane 
after protein precipitation 
with ethanol, then the 
extract was cleaned by 
Sep-Pak silica cartridge. 
HPLC-FL with a platinum 
catalyst reduction column 
(ex: 240 or 320 nm, em: 
430 nm) 
2 pg (PK), 4 
pg (MK-4), 4 





Extraction with n-hexane 
after protein precipitation 
with isopropanol. 
HPLC-FL with an on-line 
electrochemical reactor 
(ex: 320 nm, em: 430 nm) 
25 pg (PK)  [26] 
Rat plasma 
(0.5 mL) 
Extraction with n-hexane 
after protein precipitation 
with isopropanol. 
HPLC-FL with an on-line 
electrochemical reactor 
(ex: 330 nm, em: 430 nm) 




Table 1 (Continued) 
Sample 
(volume) 




Extraction with n-hexane 
after protein precipitation 
with ethanol, then the extract 
was cleaned by Sep-Pak silica 
cartridge. 
HPLC-peroxyoxlate CL 
with an on-line photo-
reactor 
14 pg (PK), 
17 pg (MK-






Extraction with n-hexane 
after protein precipitation 
with ethanol, then the extract 
was cleaned by Sep-Pak silica 
cartridge. 
HPLC-luminol CL with 
an on-line photoreactor 
6 pg (PK), 8 
pg (MK-4), 





Extraction with n-hexane 
after protein precipitation 
with ethanol, then the extract 
was cleaned by Accubond 
ODS cartridge. 
HPLC-ECD with a 
platinum catalyst 
reduction column  




Extraction with cyclohexane 
after protein precipitation 
with ethanol. 




Extraction with n-hexane 
after protein precipitation 
with ethanol, then the extract 
was cleaned by Sep-Pak silica 
cartridge. 
LC-APCI(+)-MS/MS 40 pg/mL 
(PK), 50 
pg/mL (MK-






Extraction with n-hexane 
after protein precipitation 
with methanol, then PK in the 
extract was derivatized with 
heptafluorobutyric anhydride 
after reduction with zinc. 
GC-MS 1.0 pg (PK)  [73] 
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Table 2 Analytical methods for the determination of UQ in blood samples. 
Sample 
(volume) 




hexane after protein 
precipitation with 
methanol. 




propanol after addition 




cyanoacettamide (ex: 460 
nm, em: 550 nm) 
0.16 ng  [35] 
Human plasma 
(50 µL)  
Extraction with n-
hexane after protein 
precipitation with 
ethanol and oxidation by 
H2O2. 
HPLC-CL after reaction 
with luminol and DTT 




with ethanol, then UQ in 
the supernatant was 
reduced by NaBH4 




hexane after protein 
precipitation with 
ethanol. 
HPLC-ECD with a 
platinum catalyst 
reduction column 





HPLC-ECD with a 
platinum catalyst 
reduction column and an 
on-line solid phase 
extraction system. 
1 ng/L  [49] 
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Table 2  (Continued) 
Sample 
(volume) 




Extraction with n-hexane 
after protein precipitation 
with methanol. 
HPLC-ECD with a 
platinum catalyst 
reduction column 




Extraction with n-hexane 
after addition of ethanol 
containing butylated 
hydroxytoluene. 
HPLC-ECD with an on-
line electrochemical 
reactor 




Extraction with n-hexane 
after addition of ethanol 
containing butylated 
hydroxytoluene. 
HPLC-ECD with an on-
line electrochemical 
reactor 




Protein precipitation with 
1-propanol. 
HPLC-ECD with an on-
line electrochemical 
reactor 
5 µg/L  [53] 
Human serum 
(50 µL) 
Protein precipitation with 
1-propanol after oxidation 
by 1,4-benzoquinone. 
LC-APCI(-)-MS/MS 10 pg  [60] 
Rat serum (50 
µL) 
Protein precipitation with 
2-propanol. 
LC- APCI(+)-MS 50 ng/mL  [61] 
Human serum 
(100 µL) 
Extraction with n-hexane 
after protein precipitation 
with 1-propanol. 




Extraction with n-hexane 
after protein precipitation 
with 1-propanol. 
CE-UV (abs: 214 nm) 1 µg/mL  [77] 
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Table 3 Analytical methods for the determination of DXR in blood samples. 
Sample 
(volume) 











with acetone and zinc 
sulfate. 
HPLC-FL (ex: 480 nm, em: 



















Extraction with Oasis 
HLB SPE column. 
HPLC-ECD with an on-line 
electrochemical reactor 




with acetonitrile and 
ammnonium acetate. 






Extraction with Oasis 
HLB SPE column. 









CE-UV (abs: 234 nm) 1 nM  [78] 
Human serum 
(50 µL)  
Protein precipitation 
with acetonitrile 
CE-laser induced FL (ex: 
488 nm, em: 566 nm) 





Voltammetry 1 nM  [80] 
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Table 4 Analytical methods for the determination of PAHQ in airborne particulates. 
Sample preparation Analytical technique LOD/LOQ  Ref. 
Extraction with dichloromethane 
by ultrasonication. 
HPLC-UV (abs: 254 nm)  15 ng (1,2-NQ), 
15 ng (1,4-NQ), 
3 ng (PQ), 3 ng 
(AQ) 
 [20] 
Extraction with ethanol by 
ultrasonication. 
HPLC-FL with a platinum-
rhodium catalyst reduction 
column and an on-line solid 
phase extraction system (ex: 285 




Extraction with methanol by 
ultrasonication, then PQ in the 
extract was derivatized with 
benzldehyde and ammonium 
acetate. 
HPLC-FL (ex: 265 nm, em: 390 
nm)  
5 fmol (PQ)  [32] 
Extraction with methanol by 
ultrasonication, then PQ in the 
extract was derivatized with 4-
carbomethoxybenzldehyde and 
ammonium acetate. 
HPLC-FL (ex: 370 nm, em: 465 
nm)  
1.2 fmol (PQ)  [33] 
Extraction with methanol by 
ultrasonication. 
HPLC-FL after post-column 
fluorescent derivatization with 
2-aminothiophenol (ex: 390 nm, 
em: 510 nm) 
70 fmol (PQ)  [34] 
Extraction with mixture of 
dichloromethane and methanol by 
ultrasonication. 
HPLC-luminol CL with an on-
line photoreactor 
24 fmol (1,2-
NQ), 16 fmol 
(1,4-NQ), 7 
fmol (PQ), 1.5 




Table 4 (Continued) 
Sample preparation Analytical technique LOD/LOQ  Ref. 
Extraction with mixture of 
benzene and ethanol, then the 
extract was cleaned by Sep-Pak 
silica cartridge. 
HPLC-CL after reaction with 
H2O2 and NaHSO3 
30 fmol (BaPQ)   [44] 
Extraction with ethyl acetate by 
ultrasonication. 
LC -APCI(+)-MS/MS 0.1-5.8 pg/µL  [68] 
Extraction with methanol at 
high temperature and high 
pressure in an accelerated 
solvent extractor. 
LC-APCI(-)-MS 215 pg (BaAQ), 






LC- APCI(-)-MS/MS 0.20 µg/L 
(BaAQ), 0.40 
µg/L (1,4-NQ), 
1.15 µg/L (PQ), 
0.92 µg/L (AQ) 
 [71] 
Extraction with mixture of 
dichloromethane and n-hexane, 
and methanol by 
ultrasonication, then PAHQ in 
the extract was derivatized with 
PFBHA. 
LC-APCI(+)-MS/MS 26 pg (1,4-NQ) 




ultrasonication, then PAHQ in 
the extract was derivatized with 
acetic anhydride after reduction 
with zinc. 
GC-MS 0.3 ng (1,2-NQ), 
0.4 ng (1,4-NQ), 
0.2 ng (PQ) and 
4.8 ng (AQ) 
 [75] 
 
